Skip to content
Homepage
Author:
Kuros Biosciences AG
Posted Date:
June 17, 2026
Kuros Biosciences to showcase MagnetOs™ commercial momentum and plan for scalable quality growth at Capital Markets Day in Zürich
Kuros Biosciences AG
June 17, 2026
Kuros Biosciences appoints I.V. Hall as Chief Operating Officer, deepening operational, R&D and extremities leadership for next phase of growth
Kuros Biosciences AG
May 7, 2026
Annual General Meeting of Kuros Biosciences approves all resolutions
Kuros Biosciences AG
April 15, 2026
Kuros Biosciences reports 51% year-over-year increase in sales in the first three months of 2026
Kuros Biosciences AG
April 14, 2026
Kuros Biosciences delivers 72% year-over-year sales growth, reaching USD 146.1 million for 2025
Kuros Biosciences AG
March 10, 2026
